O9.2. ANTIPSYCHOTIC DRUGS IMPAIR BRAIN GLUCOSE SENSING RESULTING IN WHOLE BODY INSULIN RESISTANCE

BACKGROUND: Antipsychotics (APs) remain the cornerstone treatment for schizophrenia, and are widely used on- and off-label for other psychiatric disorders. However, their use presents a significant risk for serious adverse glycemic effects. Independent of changes in adiposity, APs directly dysregula...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellani, Laura, Kowalchuk, Chantel, Asgariroozbehani, Roshanak, Tran, Veronica, Brett McIntyre, William, Hamel, Laurie, Remington, Gary, Giacca, Adria, Hahn, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Oral Session: Digital Health/Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233993/
http://dx.doi.org/10.1093/schbul/sbaa028.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233993/
http://dx.doi.org/10.1093/schbul/sbaa028.049

Ejemplares similares